FDA Seizes Implantable Devices from NJ Firm

FDA announced that it has seized all devices made by Shelhigh, Inc. (Union, NJ) after finding significant manufacturing deficiencies, especially failure to maintain sterility. According to the Associated Press, the agency inspected Shelhigh's plant last fall and found that deficiencies described in warning letters from 2000 and 2005 had not been satisfied.

April 18, 2007

1 Min Read
FDA Seizes Implantable Devices from NJ Firm

It had told the company that it would seize product if the problems were not corrected, and that is what has happened. Apparently the most egregious offense is a poorly constructed and poorly maintained cleanroom.Shelhigh's products are tissue-based and are used in a number of high-risk surgical settings, which may have contributed to the agency's haste to take action. The products include pediatric heart valves and conduits, surgical patches, dural patches, annuloplasty rings, and arterial grafts. Among the applications for Shelhigh's products are open heart surgery in adults, children, and infants, and repair of soft tissue during neurosurgery and abdominal, pelvic, and thoracic surgery. Doctors are advised to use alternative products, and to monitor patients who already have Shelhigh implants.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like